🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
RATIONALE: Monoclonal antibodies, such as bevacizumab, can block tumor grow...
Status
Unknown
Location
Memorial Sloan-Kettering Cancer Center
Start Date
2006-07
Trial ID
NCT00436709
This study aims to evaluate the clinical feasibility of first-line immunoch...
Status
Not Yet Recruiting
Location
The Obstetrics and Gynecology Hospital of Fudan University
Start Date
2025-03-10
Trial ID
NCT06878196
Treatments Being Tested
This is a multicenter, open-label, phase II clinical study conducted in Chi...
Status
Completed
Location
Hunan Cancer Hospital
Start Date
2021-04-01
Trial ID
NCT04868708
Treatments Being Tested
This is a single center, open-label, nonrandomized, phase 1b study of TRC10...
Status
Completed
Location
UAB Comprehensive Cancer Center
Start Date
2015-11-02
Trial ID
NCT02429843
Treatments Being Tested
To compare treatment with SU011248 plus paclitaxel versus bevacizumab plus ...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2006-11
Trial ID
NCT00373256
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy, such as hydroxychloroquine, carbopla...
Status
Terminated
Location
Cancer Institute of New Jersey at Hamilton
Start Date
2008-06-16
Trial ID
NCT00728845
Treatments Being Tested
This study is designed to evaluate the efficacy and safety of first-line tr...
Status
Completed
Location
Gemeinschaftspraxis für Hämatologie und Onkologie
Start Date
2018-05-24
Trial ID
NCT03462251
This randomized, Phase III, multicenter, open-label study designed to evalu...
Status
Unknown
Location
Samsung Medical Center
Start Date
2019-08-27
Trial ID
NCT03991403
Treatments Being Tested
The most likely way to improve survival and cure rates in treating ovarian ...
Status
Completed
Location
Gynecologic Oncology Associates
Start Date
2004-08
Trial ID
NCT00127920
Treatments Being Tested
A phase II Study of an adapted chemotherapy regimen plus bevacizumab in eld...
Status
Unknown
Location
Hospital Virgen de los Lirios
Start Date
2013-08
Trial ID
NCT01980472
Treatments Being Tested